Metabolic Disorders and Inflammatory Bowel Diseases

Area of Science:

• Gastroenterology and Hepatology
• Immunology
• Metabolic Medicine

Background:

• Inflammatory bowel disease (IBD) is defined by chronic immune-mediated intestinal inflammation.
• IBD presents with diverse metabolic disorders and both intestinal and extraintestinal manifestations.
• Contributing factors include lifestyle, genetics, immune system dysfunction, and gut microbiota composition.

Purpose of the Study:

• To review current knowledge on metabolic comorbidities associated with IBD.
• To examine emerging metabolic disorders and extraintestinal manifestations in IBD patients.
• To elucidate the clinical significance of these associated conditions for patient outcomes.

Main Methods:

• Literature review of existing studies on IBD comorbidities.
• Analysis of research focusing on metabolic disorders (e.g., NAFLD, T2DM, obesity) in IBD.
• Synthesis of data on extraintestinal manifestations and their clinical impact.

Main Results:

• IBD is frequently associated with cardiovascular diseases, thrombosis, and metabolic disorders.
• Nonalcoholic fatty liver disease, type 2 diabetes mellitus, and obesity are key metabolic comorbidities in IBD.
• Effective identification and management of these conditions are crucial for improving patient prognosis.

Conclusions:

• Metabolic disorders and extraintestinal manifestations are significant aspects of IBD management.
• Addressing these comorbidities can enhance overall patient care and outcomes in IBD.
• Further research is needed to fully understand and manage the complex interplay of IBD and its associated conditions.